| # | Drug | Count |
|---|---|---|
| 0 | PEMBROLIZUMAB | 35 |
| 1 | NIVOLUMAB | 14 |
| 2 | CARBOPLATIN | 13 |
| 3 | PEMETREXED DISODIUM | 10 |
| 4 | IPILIMUMAB | 9 |
| 5 | PEMETREXED | 5 |
| 6 | PACLITAXEL | 4 |
| 7 | PACLITAXEL (AIBUMIN-BOUND) | 4 |
| 8 | TRASTUZUMAB | 4 |
| 9 | AXITINIB | 3 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PLATINUM | 1 | 0.0019 |
| 1 | SENNOSIDES A AND B | 1 | 0.0006 |
| 2 | UREA | 1 | 0.0005 |
| 3 | PEMBROLIZUMAB | 35 | 0.0003 |
| 4 | PEMETREXED DISODIUM | 10 | 0.0003 |
| 5 | IPILIMUMAB | 9 | 0.0002 |
| 6 | KETOROLAC TROMETHAMINE | 1 | 0.0002 |
| 7 | EPIRUBICIN HYDROCHLORIDE | 1 | 0.0002 |
| 8 | AXITINIB | 3 | 0.0002 |
| 9 | NIVOLUMAB | 14 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 49 | 0.0005 |
| 1 | CTLA-4-directed Blocking Antibody [EPC] | 9 | 0.0002 |
| 2 | Programmed Death Ligand-1 Blocker [EPC] | 3 | 0.0001 |
| 3 | Alkaloid [EPC] | 2 | 0.0001 |
| 4 | Orexin Receptor Antagonist [EPC] | 1 | 0.0001 |
| 5 | HER2/neu Receptor Antagonist [EPC] | 4 | 0.0001 |
| 6 | Platinum-based Drug [EPC] | 13 | 0.0000 |
| 7 | Epidermal Growth Factor Receptor Antagonist [EPC] | 2 | 0.0000 |
| 8 | Microtubule Inhibitor [EPC] | 4 | 0.0000 |
| 9 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |